Cited by 56Gastrointestinal motility and disordersIon Transport and Channel RegulationDrug Transport and Resistance Mechanisms

SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation

Open access
Haggie, Peter M., Cil, Onur, Lee, Sujin, Tan, Joseph-Anthony, Rivera, Amber A., Phuan, Puay-Wah, Verkman, Alan S.·2018·JCI Insight

Abstract

SLC26A3 (downregulated in adenoma; DRA) is a Cl – /anion exchanger expressed in the luminal membrane of intestinal epithelial cells, where it facilitates electroneutral NaCl absorption. SLC26A3 loss of function in humans or mice causes chloride-losing diarrhea. Here, we identified slc26a3 inhibitors in a screen of 50,000 synthetic small molecules done in Fischer rat thyroid (FRT) cells coexpressing slc26a3 and a genetically encoded halide sensor. Structure-activity relationship studies were done on the most potent inhibitor classes identified in the screen: 4,8-dimethylcoumarins and acetamide-thioimidazoles. The dimethylcoumarin DRA inh -A250 fully and reversibly inhibited slc26a3-mediated Cl – exchange with HCO 3 – , I – , and thiocyanate (SCN – ), with an IC 50 of ~0.2 μM. DRA inh -A250 did not inhibit the homologous anion exchangers slc26a4 (pendrin) or slc26a6 (PAT-1), nor did it alter activity of other related proteins or intestinal ion channels. In mice, intraluminal DRA inh -A250 blocked fluid absorption in closed colonic loops but not in jejunal loops, while the NHE3 (SLC9A3) inhibitor tenapanor blocked absorption only in the jejunum. Oral DRA inh -A250 and tenapanor comparably reduced signs of constipation in loperamide-treated mice, with additive effects found on coadministration. DRA inh -A250 was also effective in loperamide-treated cystic fibrosis mice. These studies support a major role of slc26a3 in colonic fluid absorption and suggest the therapeutic utility of SLC26A3 inhibition in constipation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.121370

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DRAinh-A250 blocked fluid absorption in mouse colonic loops and reversed loperamide-induced constipation when administered intraluminally.

    “When administered intraluminally, DRAinh-A250 blocked fluid absorption in mouse colonic loops and reversed loperamideinduced constipation”

    From Irritable bowel syndrome (2020) · cites this paper as [140]

    The distal-colon loop results report that DRAinh-A250 administered directly into mouse colonic loops prevented fluid absorption. The constipation results, however, describe oral administration that partially prevented loperamide-induced reductions in stool measures—not intraluminal administration that reversed established constipation. (LLM, conf=0.91)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Schweinfest CW, Henderson KW, Suster S, Kondoh N, Papas TS. Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. Proc Natl Acad Sci USA. 1993;90(9):4166-4170. · DOI
  2. Byeon MK, et al. The down-regulated in adenoma (DRA) gene encodes an intestine-specific membrane glycoprotein. Oncogene. 1996;12(2):387-396.
  3. Höglund P, et al. Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea. Nat Genet. 1996;14(3):316-319. · DOI
  4. Walker NM, et al. Down-regulated in adenoma Cl/HCO3 exchanger couples with Na/H exchanger 3 for NaCl absorption in murine small intestine. Gastroenterology. 2008;135(5):1645-1653.e3. · DOI
  5. Shcheynikov N, et al. Coupling modes and stoichiometry of Cl -/HCO 3 -exchange by slc26a3 and slc26a6. J Gen Physiol. 2006;127(5):511-524. · DOI
  6. Dorwart MR, Shcheynikov N, Yang D, Muallem S. The solute carrier 26 family of proteins in epithelial ion transport. Physiology (Bethesda). 2008;23:104-114.
  7. Alper SL, et al. Native and recombinant Slc26a3 (downregulated in adenoma, Dra) do not exhibit properties of 2Cl -/1HCO 3 - exchange. Am J Physiol, Cell Physiol. 2011;300(2):C276-C286. · DOI
  8. Alper SL, Sharma AK. The SLC26 gene family of anion transporters and channels. Mol Aspects Med. 2013;34(2-3):494-515. · DOI
  9. Schweinfest CW, et al. slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon. J Biol Chem. 2006;281(49):37962-37971. · DOI
  10. Walker NM, et al. Role of down-regulated in adenoma anion exchanger in HCO 3 -secretion across murine duodenum. Gastroen- terology. 2009;136(3):893-901. · DOI
  11. Talbot C, Lytle C. Segregation of Na/H exchanger-3 and Cl/HCO3 exchanger SLC26A3 (DRA) in rodent cecum and colon. Am J Physiol Gastrointest Liver Physiol. 2010;299(2):G358-G367. · DOI
  12. Kato A, Romero MF. Regulation of electroneutral NaCl absorption by the small intestine. Annu Rev Physiol. 2011;73:261-281. · DOI
  13. Xiao F, et al. Slc26a3 deficiency is associated with loss of colonic HCO 3 -secretion, absence of a firm mucus layer and barrier impairment in mice. Acta Physiol (Oxf). 2014;211(1):161-175. · DOI
  14. Wedenoja S, Höglund P, Holmberg C. Review article: the clinical management of congenital chloride diarrhoea. Aliment Phar- macol Ther. 2010;31(4):477-485. · DOI
  15. Wedenoja S, Pekansaari E, Höglund P, Mäkelä S, Holmberg C, Kere J. Update on SLC26A3 mutations in congenital chloride diarrhea. Hum Mutat. 2011;32(7):715-722. · DOI
  16. van der Doef HP, Kokke FT, van der Ent CK, Houwen RH. Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep. 2011;13(3):265-270. · DOI
  17. Wall SM, Lazo-Fernandez Y. The role of pendrin in renal physiology. Annu Rev Physiol. 2015;77:363-378. · DOI
  18. Haggie PM, Phuan PW, Tan JA, Zlock L, Finkbeiner WE, Verkman AS. Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis. FASEB J. 2016;30(6):2187-2197. · DOI
  19. Cil O, Haggie PM, Phuan PW, Tan JA, Verkman AS. Small-molecule inhibitors of pendrin potentiate the diuretic action of furosemide. J Am Soc Nephrol. 2016;27(12):3706-3714. · DOI
  20. Simpson JE, et al. PAT-1 (Slc26a6) is the predominant apical membrane Cl -/HCO 3 -exchanger in the upper villous epithelium of the murine duodenum. Am J Physiol Gastrointest Liver Physiol. 2007;292(4):G1079-G1088. · DOI
  21. Walker NM, et al. Functional activity of Pat-1 (Slc26a6) Cl -/HCO 3 -exchange in the lower villus epithelium of murine duode- num. Acta Physiol (Oxf). 2011;201(1):21-31. · DOI
  22. Garazd MM, Garazd YL, Khilya VP. Neoflavines. 2. Methods for synthesizing and modifying 4-arylcoumarins. Chem Nat Compd. 2005;41(3):245-271. · DOI
  23. Li B, et al. Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical opti- mization, biological evaluation, and antibacterial activities. J Med Chem. 2012;55(24):10896-10908. · DOI
  24. Chey WD, Lembo AJ, Rosenbaum DP. Tenapanor treatment of patients with constipation-predominant irritable bowel syn- drome: A phase 2, randomized, placebo-controlled efficacy and safety Trial. Am J Gastroenterol. 2017;112(5):763-774. · DOI · Paper page
  25. Cil O, et al. CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipation. Cell Mol Gastroenterol Hepatol. 2016;2(3):317-327. · DOI
  26. Cil O, et al. Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipation. Transl Res. 2017;182:14-26.e4. · DOI
  27. Camilleri M, et al. Chronic constipation. Nat Rev Dis Primers. 2017;3:17095.
  28. Bharucha AE, Wouters MM, Tack J. Existing and emerging therapies for managing constipation and diarrhea. Curr Opin Phar- macol. 2017;37:158-166. · DOI
  29. Son JH, et al. High-potency phenylquinoxalinone cystic fibrosis transmembrane conductance regulator (CFTR) activators. J Med Chem. 2017;60(6):2401-2410. · DOI
  30. Magalhães D, Cabral JM, Soares-da-Silva P, Magro F. Role of epithelial ion transports in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2016;310(7):G460-G476. · DOI
  31. Sabharwal S. Gastrointestinal manifestations of cystic fibrosis. Gastroenterol Hepatol (N Y). 2016;12(1):43-47.
  32. Ledoussal C, Woo AL, Miller ML, Shull GE. Loss of the NHE2 Na(+)/H(+) exchanger has no apparent effect on diarrheal state of NHE3-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2001;281(6):G1385-G1396. · DOI
  33. Schultheis PJ, et al. Renal and intestinal absorptive defects in mice lacking the NHE3 Na + /H + exchanger. Nat Genet. 1998;19(3):282-285. · DOI
  34. Wang Z, Petrovic S, Mann E, Soleimani M. Identification of an apical Cl -/HCO 3 -exchanger in the small intestine. Am J Physiol Gastrointest Liver Physiol. 2002;282(3):G573-G579. · DOI
  35. Seidler U, et al. Sodium and chloride absorptive defects in the small intestine in Slc26a6 null mice. Pflugers Arch. 2008;455(4):757-766.
  36. Freel RW, Whittamore JM, Hatch M. Transcellular oxalate and Cl -absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate. Am J Physiol Gastrointest Liver Physiol. 2013;305(7):G520-G527. · DOI
  37. Hemminki A, et al. Intestinal cancer in patients with a germline mutation in the down-regulated in adenoma (DRA) gene. Onco- gene. 1998;16(5):681-684. · DOI
  38. Hihnala S, Höglund P, Lammi L, Kokkonen J, Ormälä T, Holmberg C. Long-term clinical outcome in patients with congenital chloride diarrhea. J Pediatr Gastroenterol Nutr. 2006;42(4):369-375. · DOI
  39. Asano K, et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet. 2009;41(12):1325-1329. · DOI
  40. Priyamvada S, Gomes R, Gill RK, Saksena S, Alrefai WA, Dudeja PK. Mechanisms underlying dysregulation of electrolyte absorption in inflammatory bowel disease-associated diarrhea. Inflamm Bowel Dis. 2015;21(12):2926-2935. · DOI
  41. Wedenoja S, et al. A missense mutation in SLC26A3 is associated with human male subfertility and impaired activation of CFTR. Sci Rep. 2017;7(1):14208. · DOI
  42. Xu X, Kasembeli MM, Jiang X, Tweardy BJ, Tweardy DJ. Chemical probes that competitively and selectively inhibit Stat3 acti- vation. PLoS One. 2009;4(3):e4783. · DOI
  43. Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. Biomed Res Int. 2013;2013:963248.
  44. Haggie PM, et al. Correctors and potentiators rescue function of the truncated W1282X-cystic fibrosis transmembrane regulator (CFTR) translation product. J Biol Chem. 2017;292(3):771-785. · DOI
  45. Ma T, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110(11):1651-1658. · DOI
  46. Namkung W, Phuan PW, Verkman AS. TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J Biol Chem. 2011;286(3):2365-2374. · DOI

Cited by

Sorted by citations

Authors
Haggie, P. M., Cil, O., Lee, S., Tan, J.-A., Rivera, A. A., Phuan, P.-W., & Verkman, A. S.
Affiliations
  • Department of Medicine,
  • University of California, San Francisco (US)
Corresponding author
  • Haggie, Peter M.
  • Verkman, Alan S.
Venue
JCI Insight
Published
2018-07-26
Volume
3
Issue
14
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2883970497
Cited by
56
References
1
Citations by year
2026: 4 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 9 · 2020: 6 · 2019: 9
FWCI
5.95
Type
journal article
Language
en
Open access
Locations
  • JCI Insight (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
NIDDK, NEI, Cystic Fibrosis Foundation, Cystic Fibrosis Research Inc. (DK099803,DK72517,DK101373,EY13573,CFF,R613,CFRI New Horizons)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
SLC26A3, chloride exchange, constipation, small molecule inhibitors, tenapanor, NHE3 inhibition, loperamide, cystic fibrosis, intestinal epithelium
MeSH terms
Sodium-Hydrogen Exchanger 3, Sulfate Transporters, Animals, Chlorides, Constipation, Cystic Fibrosis, Disease Models, Animal, Drug Evaluation, Preclinical, Epithelial Cells, Humans, Loperamide, Rats, Inbred F344, Ion Transport, Antiporters, Chloride-Bicarbonate Antiporters, Mice, Rats, High-Throughput Screening Assays, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review